Rocket Pharmaceuticals, Inc.
NASDAQ:RCKTBiotechnology
Healthcare
$2.11 +1.84%
+$0.06 today
- Market cap
- $235.60M
- Beta
- 0.47
- P/E (TTM)
- -1.7
- EPS (TTM)
- -$1.87
52W Low $2.40High $5.45
Volume 1.79M
Average 3.15M
Price history
Rocket Pharmaceuticals, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-28.23%
Period high
$5.30
Period low
$2.11
Latest
$2.11
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 4 | Nov 12, 2026 | Nov 12, 2026 | |
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| 4 | Nov 9, 2026 | Nov 9, 2026 | |
| SC 13G/A | Oct 30, 2026 | Oct 30, 2026 | |
| 8-K | Oct 6, 2026 | Oct 6, 2026 | |
| 4 | Sep 15, 2026 | Sep 15, 2026 | |
| 8-K | Sep 15, 2026 | Sep 15, 2026 | |
| 25-NSE | Sep 2, 2026 | Sep 2, 2026 | |
| 8-K | Aug 27, 2026 | Aug 27, 2026 | |
| 4 | Aug 20, 2026 | Aug 20, 2026 | |
| 4 | Aug 20, 2026 | Aug 20, 2026 | |
| 4 | Aug 17, 2026 | Aug 17, 2026 | |
| 4 | Aug 17, 2026 | Aug 17, 2026 | |
| 4 | Aug 13, 2026 | Aug 13, 2026 |
Competitors
Who does Rocket Pharmaceuticals, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about RCKT's filings, answered from its disclosures.
What is the latest RCKT filing?
The latest filing shown is 4 dated Nov 12, 2026.
How many recent filings does RCKT have?
Intrinsic Alpha currently shows 20 recent filings for RCKT.
Continue the stock analysis
Jump to another research area for this company.